At Bancorp buys $8.2 Million stake in CVS Health Corp (CVS)

CVS Health Corp (CVS) : At Bancorp scooped up 20,093 additional shares in CVS Health Corp during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 13, 2016. The investment management firm now holds a total of 79,408 shares of CVS Health Corp which is valued at $8.2 Million.CVS Health Corp makes up approximately 1.26% of At Bancorp’s portfolio.

Other Hedge Funds, Including , Davidson Investment Advisors sold out all of its stake in CVS during the most recent quarter. The investment firm sold 1,440 shares of CVS which is valued $149,285.Stack Financial Management Inc reduced its stake in CVS by selling 2,589 shares or 0.93% in the most recent quarter. The Hedge Fund company now holds 274,989 shares of CVS which is valued at $28.5 Million. CVS Health Corp makes up approx 3.43% of Stack Financial Management Inc’s portfolio.Skba Capital Management reduced its stake in CVS by selling 2,660 shares or 41.56% in the most recent quarter. The Hedge Fund company now holds 3,740 shares of CVS which is valued at $387,726. CVS Health Corp makes up approx 0.04% of Skba Capital Management’s portfolio.Financial Counselors Inc boosted its stake in CVS in the latest quarter, The investment management firm added 22,906 additional shares and now holds a total of 47,739 shares of CVS Health Corp which is valued at $4.9 Million. CVS Health Corp makes up approx 0.31% of Financial Counselors Inc’s portfolio.

CVS Health Corp opened for trading at $97.61 and hit $98.23 on the upside on Wednesday, eventually ending the session at $97.55, with a gain of 0.17% or 0.17 points. The heightened volatility saw the trading volume jump to 71,21,759 shares. Company has a market cap of $104,771 M.

On the company’s financial health, CVS Health Corp reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on May 3, 2016. Analyst had a consensus of $1.16. The company had revenue of $43215.00 million for the quarter, compared to analysts expectations of $43000.77 million. The company’s revenue was up 18.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS.

Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Mizuho on May 4, 2016 to “Buy”, Firm has raised the Price Target to $ 117 from a previous price target of $104 .Company shares were Reiterated by RBC Capital Mkts on May 4, 2016 to “Outperform”, Firm has raised the Price Target to $ 115 from a previous price target of $110 .Company shares were Reiterated by Barclays on Mar 10, 2016 to “Overweight”, Firm has raised the Price Target to $ 115 from a previous price target of $110 .

CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.

Leave a Reply

CVS Health Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on CVS Health Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.